Neonatal Outcomes Following Selective Serotonin Reuptake Inhibitor Use During Pregnancy - Top-Institutions - MDSpire

Neonatal Outcomes Following Selective Serotonin Reuptake Inhibitor Use During Pregnancy

  • By

  • Layla Aref

  • Jacob J. Hughey

  • Sherwin Shirazi

  • Jennifer M. S. Sucre

  • Lisa Bastarache

  • July 13, 2026

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, Tennessee

    Key Differentiators

    • Psychiatry

  • #2

    Danish Medical Birth Register
    Danish Medical Birth Register

    Copenhagen, Denmark

    Key Differentiators

    • Public Health

  • #3

    Swedish Medical Birth Register
    Swedish Medical Birth Register

    Stockholm, Sweden

    Key Differentiators

    • Public Health

  • #4

    Abano Polyclinic
    Abano Polyclinic

    Abano Terme, Italy

    Key Differentiators

    • Obstetrics

  • #5

    Jeju National University
    Jeju National University

    Jeju, South Korea

    Key Differentiators

    • Research

Original Source(s)

Neonatal Outcomes Following Selective Serotonin Reuptake Inhibitor Use During Pregnancy

  • by Layla Aref, Jacob J. Hughey, Sherwin Shirazi, Jennifer M. S. Sucre, Lisa Bastarache

  • July 13, 2026

Related Content

Clinical, metabolomic, and proteomic profiles associated with reproductive outcomes in unexplained recurrent pregnancy loss

Health and Socioeconomic Factors in School Readiness and Achievement Among Children Born Very Preterm

Comparative analysis of sperm preparation techniques on DNA fragmentation and clinical outcomes: a network meta-analysis